CymaBay Therapeutics, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
CymaBay Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2012 to Q4 2023.
  • CymaBay Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $170M, a 17.2% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $170M +$24.8M +17.2% Dec 31, 2023 10-K 2024-02-28
Q4 2022 $145M -$29.2M -16.8% Dec 31, 2022 10-K 2024-02-28
Q4 2021 $174M +$14.7M +9.26% Dec 31, 2021 10-K 2023-03-23
Q4 2020 $159M +$17.2M +12.1% Dec 31, 2020 10-K 2022-03-17
Q4 2019 $142M +$23.6M +19.9% Dec 31, 2019 10-K 2021-03-25
Q4 2018 $118M +$29.5M +33.2% Dec 31, 2018 10-K 2020-03-16
Q4 2017 $88.9M -$32.7M -26.9% Dec 31, 2017 10-K 2019-02-28
Q4 2016 $122M +$9.74M +8.71% Dec 31, 2016 10-K 2018-03-15
Q4 2015 $112M +$9.82M +9.62% Dec 31, 2015 10-K 2017-03-23
Q4 2014 $102M +$11.2M +12.3% Dec 31, 2014 10-K 2016-03-29
Q4 2013 $90.8M -$1.76M -1.9% Dec 31, 2013 10-K 2015-03-23
Q4 2012 $92.6M Dec 31, 2012 10-K 2014-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.